Q1 2026 Balchem Corp Earnings Call Transcript
Key Points
- Balchem Corp (BCPC) reported record first quarter consolidated sales, adjusted EBITDA, adjusted net earnings, and adjusted EPS, along with strong cash flows.
- The company achieved year-over-year sales and earnings growth in all three reporting segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
- Balchem Corp (BCPC) has experienced 27 consecutive quarters of quarterly year-over-year growth in adjusted EBITDA.
- The Human Nutrition & Health segment performed well, driven by demand for minerals, nutrients, and vitamins, aligning with trends toward nutrient-dense, high-protein, high-fiber, and low-sugar foods.
- The company made significant progress on strategic initiatives, including a peer-reviewed study on VitaCholine, which showed enhanced brain efficiency in post-menopausal women, and surpassed its 2030 sustainability goals for greenhouse gas emissions reduction.
- Balchem Corp (BCPC) is entering a period of significant inflation, primarily impacting the Animal Nutrition & Health segment, with potential supply chain disruptions due to geopolitical conflicts.
- The company anticipates modest margin compression due to the timing lag between input cost inflation and pricing adjustments.
- Operating expenses increased to $45 million from $37 million in the prior year, primarily due to higher compensation-related costs and professional services.
- The effective tax rate increased to 23.3% from 22.7% in the prior year, primarily due to an increase in certain state taxes.
- The company faces potential impacts from the Middle East conflict on the animal nutrition markets, with increased raw material and freight costs that may need to be offset or passed on to customers.
Thank you for standing by, and welcome to the Balchem's First quarter 2026 earnings conference call. (Operator Instructions)
I'd now like to turn the call over to Martin Bengtsson, Chief Financial Officer. You may begin.
Thank you. Good morning, everyone. Thank you for joining our conference call this morning to discuss the results of Balchem Corporation for the quarter ending March 31, 2026. My name is Martin Bengtsson, Chief Financial Officer; and hosting this call with me is Ted Harris, our Chairman, President and CEO.
Following the advice of our counsel, auditors and the SEC, at this time, I would like to read our forward-looking statements. Statements made in today's call that are not historical facts are considered forward-looking statements. We can give no assurance that the expectations reflected in forward-looking statements will prove correct, and various factors could cause actual results to differ materially from our expectations, including risks
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
